Literature DB >> 24173432

Pathogenesis of endometriosis: the role of initial infection and subsequent sterile inflammation (Review).

Hiroshi Kobayashi1, Yumi Higashiura, Hiroshi Shigetomi, Hirotaka Kajihara.   

Abstract

Endometriosis is a common type of chronic inflammatory disease with an immunological background. In this review, we aimed to explore the contemporary literature on the infection and sterile inflammation that support the pathogenesis of endometriosis. This article reviews the English‑language literature on inflammatory, environmental, immunological and oxidative factors associated with endometriosis in an effort to identify factors that cause a predisposition to endometriosis. Intrauterine microbes may be critical for the initiation of endometriosis; the initial activation of pathogen recognition receptors by microbial stimuli results in the activation of proinflammatory pathways and innate immunity. In addition to their response to various exogenous pathogen‑associated molecular patterns, Toll‑like receptors (TLRs) also recognize a wide range of endogenous danger‑associated molecular patterns (DAMPs). The increased expression levels of DAMPs may be involved in the subsequent process of nuclear transcription factor‑κB‑dependent sterile inflammation. Oxidative stress, secondary to the influx of iron during retrograde menstruation, is involved in the progression of endometriosis. DAMP‑mediated danger signals and oxidative stress are bidirectional during sterile inflammation (danger signal spiral). This review supports the hypothesis that there are at least two distinct phases of endometriosis development: The initial wave of TLR activation in modulating innate immune responses would be followed by the second big wave of sterile inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173432     DOI: 10.3892/mmr.2013.1755

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  37 in total

Review 1.  Potential scenarios leading to ovarian cancer arising from endometriosis.

Authors:  Hiroshi Kobayashi
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

2.  High mobility group box-1 promotes inflammation in endometriotic stromal cells through Toll-like receptor 4/nuclear factor-kappa B.

Authors:  Bo Hyon Yun; Sunghoon Kim; Seung Joo Chon; Ga Hee Kim; Young Sik Choi; SiHyun Cho; Byung Seok Lee; Seok Kyo Seo
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 3.  The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases.

Authors:  Yongbo Wang; Xingyu Liu; Panpan Xia; Zhangwang Li; Xinxi FuChen; Yunfeng Shen; Peng Yu; Jing Zhang
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

4.  Maternal and Paternal Infertility Disorders and Treatments and Autism Spectrum Disorder: Findings from the Study to Explore Early Development.

Authors:  Laura A Schieve; Carolyn Drews-Botsch; Shericka Harris; Craig Newschaffer; Julie Daniels; Carolyn DiGuiseppi; Lisa A Croen; Gayle C Windham
Journal:  J Autism Dev Disord       Date:  2017-12

5.  Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models.

Authors:  Stephen S Palmer; Melis Altan; Deborah Denis; Enrico Gillio Tos; Jean-Pierre Gotteland; Kevin G Osteen; Kaylon L Bruner-Tran; Selvaraj G Nataraja
Journal:  Reprod Sci       Date:  2015-09-02       Impact factor: 3.060

6.  MiR-202 promotes endometriosis by regulating SOX6 expression.

Authors:  Dongli Zhang; Yanyun Li; Jun Tian; Hongxia Zhang; Shelian Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 7.  Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: Translating lessons from murine models.

Authors:  Kaylon L Bruner-Tran; Juan Gnecco; Tianbing Ding; Dana R Glore; Virginia Pensabene; Kevin G Osteen
Journal:  Reprod Toxicol       Date:  2016-07-14       Impact factor: 3.143

8.  CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis.

Authors:  Jung-Yoon Yoo; Heesung Shin; Tae Hoon Kim; Won-Seok Choi; Susan D Ferguson; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Un-Hwan Ha; Jae-Wook Jeong
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 9.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06

10.  Treatment efficacy for pain complaints in women with endometriosis of the lesser pelvis after laparoscopic electroablation vs. CO2 laser ablation.

Authors:  Ewa Posadzka; Robert Jach; Kazimierz Pityński; Marcin Jacek Jablonski
Journal:  Lasers Med Sci       Date:  2014-07-23       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.